Prader-Willi syndrome

作者: Suzanne B. Cassidy , Stuart Schwartz , Jennifer L. Miller , Daniel J. Driscoll

DOI: 10.1038/GIM.0B013E31822BEAD0

关键词:

摘要: Prader-Willi syndrome is characterized by severe infantile hypotonia with poor suck and failure to thrive; hypogonadism causing genital hypoplasia pubertal insufficiency; characteristic facial features; early-childhood onset obesity hyperphagia; developmental delay/mild intellectual disability; short stature; a distinctive behavioral phenotype. Sleep abnormalities scoliosis are common. Growth hormone insufficiency frequent, replacement therapy provides improvement in growth, body composition, physical attributes. Management otherwise largely supportive. Consensus clinical diagnostic criteria exist, but diagnosis should be confirmed through genetic testing. due absence of paternally expressed imprinted genes at 15q11.2-q13 paternal deletion this region (65–75% individuals), maternal uniparental disomy 15 (20–30%), or an imprinting defect (1–3%). Parent-specific DNA methylation analysis will detect >99% individuals. However, additional studies necessary identify the molecular class. There multiple region, loss which contribute complete phenotype syndrome. small nucleolar organizing RNA gene, SNORD116, seems reproduce many features. Sibling recurrence risk typically <1%, higher risks may pertain certain cases. Prenatal available. Genet Med 2012:14(1):10–26.

参考文章(163)
Carla Scaroni, S Rizzati, F Ceccato, Franco Mantero, Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency. Journal of Endocrinological Investigation. ,vol. 31, pp. 61- 65 ,(2008)
D K Kalousek, W P Robinson, I J Barrett, R G Best, L Bernard, P N Howard-Peebles, R D Wilson, F Bernasconi, A Telenius, S Langlois, Meiotic origin of trisomy in confined placental mosaicism is correlated with presence of fetal uniparental disomy, high levels of trisomy in trophoblast, and increased risk of fetal intrauterine growth restriction American Journal of Human Genetics. ,vol. 60, pp. 917- 927 ,(1997)
D. Giardino, A. Crinò, P. Marzullo, F. Malvestiti, G. Di Giorgio, G. Grugni, L. Ballarati, Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes Journal of Endocrinological Investigation. ,vol. 34, pp. 493- 497 ,(2010) , 10.3275/7203
A. Crinò, , R. Schiaffini, P. Ciampalini, S. Spera, L. Beccaria, F. Benzi, L. Bosio, A. Corrias, L. Gargantini, A. Salvatoni, G. Tonini, G. Trifirò, C. Livieri, Hypogonadism and pubertal development in Prader-Willi syndrome European Journal of Pediatrics. ,vol. 162, pp. 327- 333 ,(2003) , 10.1007/S00431-002-1132-4
T. Saville, D. Leigh, S. Manass, B. Mcdonald, B. Duffy, H. Johnston, P. R. L. Lam-Po-Tang, M.-Y. Yip, S. G. Purvis-Smith, Uniparental disomy 15 resulting from "correction" of an initial trisomy 15. American Journal of Human Genetics. ,vol. 50, pp. 1348- 1350 ,(1992)
U Surti, D H Ledbetter, A Mutirangura, W P Robinson, A Chakravarti, S L Christian, M R Line, B Huang, M Nakao, Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients. American Journal of Human Genetics. ,vol. 57, pp. 40- 48 ,(1995)
N Simon Thomas, Joyce Whittington, Marijcke W M Veltman, Russell J Thompson, Patrick F Bolton, Patrick F Bolton, Sian E Roberts, Prader-Willi syndrome ,(2004)
Bernhard Horsthemke, Karin Buiting, Genomic imprinting and imprinting defects in humans. Advances in Genetics. ,vol. 61, pp. 225- 246 ,(2008) , 10.1016/S0065-2660(07)00008-9
MC Varela, F Kok, N Setian, CA Kim, CP Koiffmann, Impact of molecular mechanisms, including deletion size, on Prader–Willi syndrome phenotype: study of 75 patients Clinical Genetics. ,vol. 67, pp. 47- 52 ,(2004) , 10.1111/J.1399-0004.2005.00377.X
Butler Mg, Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome. American Journal of Human Genetics. ,vol. 45, pp. 140- 146 ,(1989)